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Abstract
Nickel (Ni) compounds have been found to cause cancer in humans and animal models and to transform cells in
culture. At least part of this effect is mediated by stabilization of hypoxia inducible factor (HIF1a) and activating its
downstream signaling. Recent studies reported that hypoxia signaling might either antagonize or enhance c-myc
activity depending on cell context. We investigated the effect of nickel on c-myc levels, and demonstrated that
nickel, hypoxia, and other hypoxia mimetics degraded c-myc protein in a number of cancer cells (A549, MCF-7, MDA-
453, and BT-474). The degradation of the c-Myc protein was mediated by the 26S proteosome. Interestingly,
knockdown of both HIF-1a and HIF-2a attenuated c-Myc degradation induced by Nickel and hypoxia, suggesting the
functional HIF-1a and HIF-2a was required for c-myc degradation. Further studies revealed two potential pathways
mediated nickel and hypoxia induced c-myc degradation. Phosphorylation of c-myc at T58 was significantly
increased in cells exposed to nickel or hypoxia, leading to increased ubiquitination through Fbw7 ubiquitin ligase. In
addition, nickel and hypoxia exposure decreased USP28, a c-myc de-ubiquitinating enzyme, contributing to a higher
steady state level of c-myc ubiquitination and promoting c-myc degradation. Furthermore, the reduction of USP28
protein by hypoxia signaling is due to both protein degradation and transcriptional repression. Nickel and hypoxia
exposure significantly increased the levels of dimethylated H3 lysine 9 at the USP28 promoter and repressed its
expression. Our study demonstrated that Nickel and hypoxia exposure increased c-myc T58 phosphorylation and
decreased USP28 protein levels in cancer cells, which both lead to enhanced c-myc ubiquitination and proteasomal
degradation.
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Introduction
Nickel (Ni) compounds have been found to cause cancer in
humans and animal models and to transform cells in culture
[1,2,3,4]. Recent studies showed that HIF-1a antagonizes c-
Myc function and inhibits VHL-deficient renal cell carcinoma
(RCC) growth [5], while HIF-2a enhances c-Myc activity in
WT-8 and 786-O cells that predominantly express HIF-2a (but
little HIF-1a) and promotes VHL-deficient RCC tumorigenesis
[6]. Given the apparent opposite effects of HIF-1a and HIF-2a
on c-Myc, it is reasonable to ask (A) whether this phenomenon
takes place in other cancer cells and (B) what is the mechanism?
HIF-1a and HIF-2a each dimerize with constitutively-ex-
pressed HIF-1b to form transcription factor HIF-1 and HIF-
2 ,w h i c hi nt u r nr e g u l a t e st h ee x p r e s s i o no ft h eH I F - d e p e n d e n t
genes by binding to hypoxia-responsive element (HRE). This
process is important for the survival of hypoxic cancer cells.
Nickel compounds have been shown to mimic hypoxia and
activate hypoxia signaling in cells by stabilizing HIF-1a
through the inhibition of Prolyl hydroxylase that targets it for
degradation [7].
c-Myc belongs to the Myc family of transcription factors. By
modifying the expression of its target genes, c-Myc regulates
numerous biological effects, such as cell proliferation, senescence,
angiogenesis, metabolism, and genetic stability [8].
c-Myc mRNA and protein are generally expressed at low levels
in normal proliferating cells [9], but frequently by unknown
mechanisms are overexpressed in cancer cells [10]. The half life of
c-Myc is very short in quiescent cells due to proteasomal
degradation [11]; however, upon serum stimulation and cell cycle
entry, c-Myc becomes transiently stabilized by the Ras pathway,
allowing it to accumulate to high levels [12,13]. This stabilization
is not dependent on cell cycle progression [12,13]. The entire
regulatory cycle of c-Myc, from signal transduction events leading
to gene expression, to stabilization, and ultimately, degradation,
includes: 1) a growth stimulatory signal leading to new c-Myc
protein synthesis and Ras activation; 2) Ras promotes c-Myc
protein stabilization through extracellular receptor kinase (ERK)-
mediated phosphorylation of serine 62 (S62); 3) Ras activation also
prevents subsequent phosphorylation of threonine 58 (T58) by
PI3K/Akt-mediated inhibition of glycogen synthase kinase
(GSK3b), further stabilizing c-Myc and increasing c-Myc protein
levels; 4) G1 phase re-activation of GSK3b allows phosphorylation
of c-Myc on T58 (P-T58-Myc); 5) the dual phosphorylated form of
c-Myc is recognized by the Pin1 prolyl isomerase, that catalyzes
the isomerization of the Ser62-Pro63 bond; 6) protein phosphatase
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ubiquitinylation by ubiquitin ligases F box proteins (Skp2 or Fbw7)
[15]; and, 7) degradation of c-Myc by the 26S proteosome.
Here we demonstrate that in cancer cell lines c-Myc was
degraded during hypoxia and specifically in A549 cells this
degradation was dependent upon both HIF-1a and HIF-2a.
Further mechanistic studies showed that c-Myc proteasomal
degradation that was initiated by hypoxia signaling was
mediated by Fbw7 ubiquitin ligase in a T58-phosphorylation-
dependent manner. Hypoxia signaling decreased the amount of
USP28 deubiquitinating enzyme that was bound to c-Myc by
attenuating its gene expression and protein stability. These
events were coincident with an increased GSK3b-independent
phosphorylated T58-Myc, resulting in increased ubiquitination
and degradation. In addition, Ni ions and hypoxia increased the
levels of the gene silencing mark dimethylated H3 lysine 9 at
USP28 promoter region, which suppressed USP28 gene
expression, further depleting the cell of this c-Myc salvaging
enzyme.
Materials and Methods
Cell Lines and Culture Condition
Human lung carcinoma A549 cells were cultured in Ham’s F-12
K medium (Invitrogen, Frederick, MD). Human breast cancer
MCF-7 cells, human colon carcinoma HCT116 wild-type cells,
and HCT116 Fbw7
2/2 cells [16] were cultured in Dulbecco’s
Modified Eagle Medium (DMEM, Invitrogen). Human breast
cancer MDA453 and BT474 cells were cultured in DMEM/F12
medium. All media were supplemented with 10% fetal bovine
serum (FBS, ATLAS Biological, Fort Collins, CO), and 1%
penicillin/streptomycin (Grand Island, NY). Cells were main-
tained at 37uC as a monolayer in a humidified atmosphere
containing 5% CO2. When cell density reached approximately
70–80% confluence, they were treated with the Ni ions or cultured
under hypoxic conditions.
Plasmids, Antibodies, and Other Reagents
HA-tagged full-length human USP28 expression vector cmv-
HA-USP28 was kindly provided by Dr. Stephen J. Elledge [17].
pFlag-Fbw7a (human) plasmid was from Dr. Bruce E. Clurman
[18]. pRC-cmv-Myc wild type plasmid and Myc-T58A mutant
plasmid were from Dr. Rosalie Sears [14]. The following
antibodies were used: c-Myc (N-262, C-33, 9E10) (Santa Cruz),
P-T58-c-Myc (Upstate Cell Signaling), GSK3b (Upstate),
dimethylated H3 lysine 9 (H3K9m2), Rabbit IgG, mouse IgG
(Abcam), USP28 and HA (Bethyl), Flag and a-tubulin antibody
(Sigma), Ubiquitin (Invitrogen), HIF-1a antibody (BD Biosci-
ences) and HIF-2a antibody (Novus Biologicals). Primary
antibody-bound proteins were detected by using appropriate
horseradish peroxidase (HRP)-conjugated secondary antibody
(Santa Cruz Biotechnology) and an enhanced chemiluminescent
(ECL for HRP) Western blotting system (Amersham, Piscataway,
NJ). MG-132 and dimethyloxalylglycine (DMOG) were pur-
chased from Biomol International (Plymouth Meeting, PA). All
other reagents were obtained from Sigma unless otherwise
specified.
Western Blot
Cells were washed with ice-cold 16PBS twice and lysed with
ice-cold radioimmuno-precipitation assay (RIPA) buffer (50 mM
Tris-HCl, PH 7.4, 1% NP-40, 0.25%Na-deoxycholate, 150 mM
NaCl, 1 mM EDTA) supplemented with a protease inhibitor
mixture (Roche Applied Sciences, Indianapolis, IN) for 10 min
on ice. The cells were then transferred to an Eppendorf tube and
kept on ice for another 30 min, followed by centrifugation at
100006g for 10 min. The supernatant (whole cell lysate) was
collected and the concentration of protein was measured using
the Bio-Rad DC protein assay (Bio-Rad, Hercules, CA). Proteins
were separated over a SDS-PAGE gel, transferred to a PVDF
membrane and probed with a specific antibody against the target
protein. The target protein was then detected using HRP-
conjugated secondary antibodies and an ECL Western blotting
system.
Quantitative Real Time-Polymerase Chain Reaction (qRT-
PCR)
RNA was isolated from cells with the Trizol Reagent
(Invitrogen) according to the manufacturer. The isolated RNA
was purified using RNeasy Plus Micro Kit (Qiagen). RNA
concentration was then determined by measuring the absorbance
at 260 nm and 280 nm using NanoDrop ND-1000 (Thermo
Scientific). 1 mg of RNA was then reversed transcribed to cDNA
with the Superscript III First Strand Synthesis Super-Mix Kit for
qRT-PCR (Invitrogen, Carlsbad, CA). Quantitative real time-
PCR was performed to amplify USP28 and b-actin using the
following primer pairs: USP28:5 9- GGACCCTTCCTTTCTC-
CATGA -39 (forward) 59- AGGCTGACTGCCTGAGTAATGT-
C- 3 9 (reverse); b-actin:5 9- ATCGTCCACCGCAAATGCTTC-
TA -39 (forward), 59- AGCCATGCCAATCTCATCTTGTT -39
(reverse). 2 ml (for USP28) or 1 ml (for b-actin) was used in a final
volume of 20 ml PCR reaction mix containing both the forward
and reverse primers (50 nM each primer), and 10 mlS y b e r
Green Master Mix (Applied Biosystems). For each sample, PCR
was performed in triplicate. PCR analyses were carried out using
the following cycle parameters: 95uC for 10 min, followed by 40
cycles of 95uC for 15 sec, and 60uCf o r1m i n .F l u o r e s c e n c ew a s
quantified, and analyses of amplification plots were performed
with the 7300 Real Time PCR System (Applied Biosystems).
Results were expressed using the comparative cycle threshold
(Ct) method as described by the manufacturer. The DCt values
were calculated in every sample as Ct (USP28) minus Ct (b-
actin). The calculation of the relative changes in the expression
level of USP28 (DDCt) was performed by subtraction of the DCt
from the control group (normoxia: as a calibrator) to the
treatment group DC t( h y p o x i a ) .T h er e l a t i v ef o l dc h a n g ew a s
determined as follows: 2
-DDCt with DDCt, and the control levels
were set to 1.0.
Semi-quantitative PCR was performed to amplify Fbw7, Skp2
and b-actin using the following primer pairs: Skp2:5 9-ACAGT-
GAGAACATCCCCCAG-39 (forward), 59-GGTCCATAAATG-
ATCGTGGG-39 (reverse). Fbw7:5 9-GTGATAGAGCCCCAGT-
TCCA (forward), 59-CCTCAGCCAAAATTCTCCAG (reverse).
b-actin:5 9-TCACCCACACTGTGCCC ATCTACGA-39 (for-
ward), 59-CAGCGGAACCGCTCATTGCCAATGG-39 (reverse).
0.5 or 1 ml was used in a final volume of 50 ml PCR reaction mix
containing both the forward and reverse primers, dNTPs (10 mM,
1 ml each), 106 reaction buffer (5 ml), and 2U of Taq DNA
polymerase (Roche, Indianapolis, IN). The conditions for PCR are:
95uC for 2 min, followed by 28 cycles (for Skp2), or 38 cycles (for
Fbw7) or 20cycles(forb-actin) of 30 secat95uC, 30 secat 60uC, and
30 sec at 70uC. An aliquot of the PCR product was analyzed over a
1% agarose gel containing ethilium bromide (EB).
siRNA Transfection
ON-TARGET plus SMART pool siRNAs targeting human
HIF-1a (NM_001530), HIF-2a (NM_001430), Fbw7 (NM_
001013415, NM_018315, NM_033632), GSK3b (NM_002093)
c-Myc Degradation by Hypoxia
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(siRNAs targeting each gene was a pool of four independent
siRNAs). Noncoding pool siRNA was also purchased from
Dharmacon but the sequence was not provided (Catalog#:
D-001210-03). A549 cells were seeded in a 6-well plate (2.56
10
5 cells/well), and on the subsequent day cells were transfected
with 100 pmol siRNA and 5 ul RNAi Max reagent (Invitrogen)
for 48 hr, and then were treated with 1.0 mM NiSO4 or hypoxia
(1% O2) for another 24 hr.
Immunoprecipitations (IP)
Whole cell lysate was isolated as described above and the
proteins of interest were immunoprecipitated from an equivalent
amount of protein for each sample using the specific antibodies.
Antibody was incubated on a rotator at 4uC for 2 hr, and then was
immunoprecipitated with protein A/G plus agarose beads (Santa
Cruz) overnight at 4uC followed by washing 4 times (5 min each
time) with RIPA buffer containing protease and phosphatase
inhibitors. After the last wash, the supernatant was removed and
the pellet was resuspended in 40 mlo f1 6Laemmli sample buffer.
After boiling at 90–100uC for 5 min, samples were centrifuged to
pellet the agarose beads, and the resultant supernatant subjected to
Western blot analysis.
Transient Transfection
One of these plasmids (HA-cmv-USP28, pRC-cmv-Myc wild
type, Myc-T58A mutant vector, or empty vector), or all three
plasmids (pRC-cmv-Myc, pFlag-Fbw7a and HA-cmv-USP28)
were transiently transfected into A549 cells in a 6-well plate (for
Western blot) or in a 100 mm-dish (for IP) with lipofectamine
LTX reagent (Invitrogen). 24 hr after transfection, cells may be
treated with 1.0 mM NiSO4 or hypoxia (1% O2) for another
24 hr. Cells were then collected and lysed with RIPA buffer and
whole cell lysate was used for Western Blot analysis or
immunoprecipitations.
Chromation Immunoprecipitation (ChIP) Assay
8610
6 A549 cells were seeded into a 15-cm dish. On the
second day, cells were treated with 1 mM NiSO4 or cultured in
1% O2 for 24 hr. After treatment, formaldehyde was added to
each dish to a final concentration of 1%. After 10 min of
incubation in a fume hood, 1/20 volume of 2.5 M glycine was
added into each dish and incubated at room temperature (RT)
for 5 min with gentle mixing. The medium was then aspirated
and the cells were washed with ice-cold PBS twice. After the last
wash, the cells were replenished with PBS supplemented with
proteinase inhibitor and the cells were collected using a
disposable scraper. The cells were spun down at 1,0006gf o r
5 min, and the pellet was washed with ice-cold PBS twice and
lysis buffer three times. The chromatin immunoprecipitation
(ChIP) assay was performed according to the Affymetrix
Chromatin Immunoprecipitation Assay Protocol (Qiagen, Va-
lencia, CA). PCR amplification of the USP28 gene was
performed using the primers as follows: 59-CATGCCCAGGT-
TAAGAGCAT-39 (forward), 59-TTCCCATCAGGCTTTG-
TAGC-39 (reverse). The conditions of PCR amplification were
95uCf o r2m i na n d2 9c y c l e so f9 5 uC for 30 sec and 56uCf o r
30 sec, and 72uC for 30 sec. The PCR products were then
separated over a 1% agarose gel containing EB.
Statistical Analysis
Each experiment was performed at least three times and
representative data are shown. Data are reported as mean
values6standard error of the mean (SEM). Statistical differences
were calculated by using the two-tailed Student’s t-test with error
probabilities of p,0.05 to be significant.
Results
Ni Compounds Decreased c-Myc Protein Levels in
Various Cancerous Cell Lines
We have studied the effects of Ni compounds on c-Myc protein
levels in human lung carcinoma A549 cells. As shown in
Figure 1A, c-Myc protein level was decreased by NiSO4 in
A549 cells in a dose- and time-dependent manner. Additional
cancer lines were used to investigate whether the Ni-induced
c-Myc dysregulation was a general phenomenon. The results
showed that Ni compounds also decreased c-Myc in other
human cancer cell lines including MCF-7, DA453, and BT474
(Figure 1A).
c-Myc Was Degraded by Ni Compounds through a
Proteasome Pathway
Since c-Myc protein level decreased when a variety of cancer
cells were exposed to NiSO4, while the c-Myc mRNA level was
not significantly changed in Ni-exposed A549 cells (data not
shown), it is likely that Ni ions act to decrease c-Myc protein
stability. In order to assess the change in the stability of c-Myc
protein brought about by Ni ions, cells were treated with 1.0 mM
NiSO4 for 24 hr, and then incubated with 10 ug/ml of the
protein synthesis inhibitor cycloheximide (CHX). c-Myc half life
was about 38.3 min in untreated cells, but it decreased by Ni
treatment to 29.3 min (Figure 1B). Ubiquitin-mediated proteol-
ysis by the 26S proteasome has been shown to be responsible for
the relatively short life of the c-Myc protein [19]. To determine
whether a degradation process wasa s s o c i a t e dw i t hl o s so fc - M y c ,
A549 cells were pretreated with the proteasomal inhibitor (MG-
132), prior to being exposed to Ni ions. The proteasomal
inhibitor prevented the nickel-induced loss of c-Myc (Figure 1C).
Furthermore, as shown in Figure 1D, Ni ions increased
ubiquitinated c-Myc (Ub-c-Myc) levels in A549 cells. These
results indicated that Ni ions reduced c-Myc protein by activating
a proteasome-dependent degradation process that shortened the
life of c-Myc in the cell.
The Degradation of c-Myc by Ni Ions Was Dependent
upon HIF-1a and HIF-2a
Previous studies have clearly shown that Ni compounds
mimicked hypoxia, by stabilizing HIF-1a i na l lc e l ll i n et h a th a s
been studied thus far. A new finding shown in Figure 2A is that
NiionexposurealsostabilizedHIF-2a inA549cells(Figure 2A).
To further understand the role of hypoxia signaling in Ni ions-
induced c-Myc degradation, desferrioxamine (an Fe chelator,
DFO), dimethyloxallyl glycine (an oxoglutarate analogue,
DMOG), and hypoxia were utilized in A549 cells to stabilize
HIF-1 and HIF-2. The results showed DFO, DMOG and
hypoxia all caused c-Myc degradation in A549 in a time-
dependent manner (Figure 2B). Treatment with MG-132
indicated that c-Myc was degraded through a proteasome
pathway when hypoxia signaling was active in A549 cells
(Figure 2C).
To study whether HIF-1 and HIF-2 were involved in Ni-
induced c-Myc degradation, HIF-1a, HIF-2a or both were
knocked down with RNAi in A549 cells. Knocking down HIF-
1a or HIF-2a alone did not suppress c-Myc degradation that was
initiated by nickel or hypoxia; however, when both were knocked
c-Myc Degradation by Hypoxia
PLoS ONE | www.plosone.org 3 December 2009 | Volume 4 | Issue 12 | e8531down, c-Myc degradation initiated by Ni ions and hypoxia was
attenuated (Figure 2D), suggesting that both were required to
degrade c-Myc.
Fbw7, but Not Skp2, Mediated c-Myc Degradation by Ni
Ions or Hypoxia in A549 Cells
Fbw7 and Skp2 are ubiquitin ligases F box proteins that were
found to participate in c-Myc ubiquitination and proteasomal
degradation [18,20]. To investigate whether these ubiquitin ligases
were involved in hypoxia initiated c-Myc degradation, RNAi
targeting human Fbw7 or Skp2 was transfected into A549 cells and
c-Myc protein was measured after cells were treated with Ni ions
or hypoxia. As shown in Figure 3A (left panel), knocking down
Fbw7, but not Skp2, attenuated Ni ion- or hypoxia-induced c-Myc
degradation. The right panel of Figure 3A showed that Fbw7 and
Skp2 gene expression was efficiently repressed by RNAi transfec-
tion. To confirm that c-Myc degradation was mediated by Fbw7
in response to hypoxia signaling, we used the human colon
carcinoma HCT116 cell line and a derivative cell line, HCT116
Fbw7
2/2, in which both alleles of the Fbw7 gene have been
disrupted by homologous recombination [16]. Exposure of the
parental cell line to Ni or hypoxia led to a strong decrease in c-
Myc protein levels (Figure 3B). In contrast, exposure of the Fbw7-
deficient cell line to Ni or hypoxia did not decrease c-Myc levels
(Figure 3B). These results suggested that Fbw7 was essential for c-
Myc degradation.
The Degradation of c-Myc in A549 Cells Initiated by
Hypoxia Signaling Was Dependent on T58
Phosphorylation
To further study the mechanism by which hypoxia signaling
initiated c-Myc degredation, wild-type c-Myc vector or c-Myc
T58A mutant vector was transfected into A549 cells. 24 hr after
transfection, cells were cultured under hypoxic conditions (1% O2)
for an additional 24 hr. Substitution of T58 of c-Myc with alanine
prevented phosphorylation at that site. As shown in Figure 3C,
T58A mutation stopped the hypoxia initated c-Myc degradation,
underscoring the importance of T58 phosphorylation to initiate c-
Myc degradation.
Nickel Ions and Hypoxia Increased the Phosphorylation
of c-Myc at T58 in A549 Cells in a GSK3Beta Independent
Manner
The steady state level of c-Myc ubiquitination depends on an
enzymatic ubiquitin conjugation and deconjugation. To examine
the mechanism by which Ni ions produce a steady sate higher
amount of Ub-c-Myc, the cellular levels of phosphorylated c-Myc
at T58 (P-T58-Myc) were measured in Ni ion-exposed cells. A549
cells were treated with 1 mM NiSO4 or hypoxia in the absence or
presence of MG-132 for 24 hr. After treatment, the cells were
lysed and 50 mg of protein was analyzed by Western blotting using
a specific antibody to P-T58-Myc. Ni ions and hypoxia each
Figure 1. The decrease in c-Myc protein levels in A549 cells was primarily due to proteasomal degradation. (A) Various cancerous cell
lines were treated with NiSO4 at indicated concentrations for 6, 12 or 24 hr. After treatment, the cells were lysed and whole cell lysates were analyzed
by Western blot using anti-c-Myc antibody. The same membranes were then stripped and re-probed with a-tubulin antibody to assess protein
loading. The densitometric data, normalized to a-tubulin level, is expressed as fold-change from control; these values are presented between the
blots. (B) A549 cells were treated with 1.0 mM NiSO4 for 24 hr and then cycloheximide (CHX) was added to a final concentration of 10 mg/ml. Cells
were lysed at selected time intervals, whole cell lysate was then isolated for Western blot. The relative intensity of the bands was quantitated using
Image J software and normalized to the loading control. The numbers quantitating the intensity of the bands were given below the corresponding
bands and were used to fit the exponential lines by Excel, and half-lives were calculated and shown below the figure. (C) A549 cells were pretreated
with 4 mM of MG-132 for 2 hr and then NiSO4 was added into the medium for another 24 hr. After treatment, cells were lysed and 50 mg of whole cell
lysate was analyzed by Western blotting. (D) Ni compounds increased ubiquitinated c-Myc (Ub-c-Myc) in A549 cells. A549 cells were transfected with
c-Myc plasmid. 24 hr after transfection, cells were treated with NiSO4 (1 mM) in the presence of MG-132 (4 mM) for another 24 hr. Cells were then
lysed and immunoprecipitated with anti-Ubiquitin (anti-Ub) antibody or non-specific IgG. Precipitates were analyzed by immunoblotting with anti-c-
Myc (c-33) antibody (mouse).
doi:10.1371/journal.pone.0008531.g001
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presence of MG-132 (Figure 4A). Additionally, previous studies in
this laboratory demonstrated that total cellular pools of ubiquitin
were not altered by Ni ions [21].
GSK3b is the only known kinase that phosphorylates c-Myc at
T58 [22]. The role of GSK3b in Ni-induced c-Myc degradation
was examined using siRNA targeting human GSK3b. Even though
GSK3b protein expression was successfully repressed in A549
Figure 2. Knocking down both HIF-1a and HIF-2a attenuated c-Myc degradation by Ni ions and hypoxia in A549 cells. (A) NiSO4 (0.5
and 1 mM), desferrioxamine (DFO: 100 mM), and dimethyloxallyl glycine (DMOG: 1 mM) induced HIF-2a in A549 cells in a time-dependent manner. (B)
100 mM DFO, 1 mM DMOG, and hypoxia (1% O2) decreased c-Myc protein levels in A549 cells in a time-dependent manner. N is normoxia, while Hy is
hypoxia. (C) Proteasome inhibitor MG-132 prevented c-Myc degradation by hypoxia in A549 cells. (D) A549 cells were transfected with non-coding
control siRNA or siRNA targeting human HIF-1a, HIF-2a or mixture (HIF-1a RNAi and HIF-2a RNAi together) for 48 hr, and then were treated with
1.0 mM NiSO4 or hypoxia for another 24 hr. After treatment, cells were lysed and whole cell lysate was analyzed by Western blot. The same
membranes were stripped and re-probed with a-tubulin antibody as loading control. Similar data were obtained in at least two other independent
experiments; one representative blot is shown here.
doi:10.1371/journal.pone.0008531.g002
Figure 3. c-Myc degradation induced by Ni ions or hypoxia was mediated by Fbw7 in a T58-phosphorylation-dependent manner in
A549 cells. (A) A549 cells were transfected with non-coding control siRNA or siRNA targeting human Fbw7 or Skp2. At 48 hr after transfection, the
cells were treated with NiSO4 (1.0 mM) or cultured in 1% O2 (Hy) for another 24 hr. Before treatment, RNA was isolated for RT-PCR (Figure 4A: right
panel). (B) HCT116 and HCT116 Fbw7
2/2 cells were treated with NiSO4 (1.0 mM) or cultured in 1% O2 (Hy) for 24 hr. After treatment, cells were lysed
and 50 mg of whole cell lysate was analyzed by Western blotting. (C) A549 cells were transfected with either wild-type (WT) or T58A-mutant c-Myc
plasmids. At 24 hr after transfection, cells were cultured in 1% O2 (Hy) for 24 hr. Cells were then lysed and 25 mg of whole cell lysate was analyzed by
Western blotting.
doi:10.1371/journal.pone.0008531.g003
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degradation (Figure 4B), nor decrease the level of P-T58-Myc in
the presence of MG-132 (Figure 4C). These results argue that
GSK3b was not involved in c-Myc degradation in A549 cells, and
that other kinases that phosphorylate c-Myc at T58 were involved
in this pathway.
Ni Ions or Hypoxia Decreased USP 28 c-Myc De-
Ubiquitinating Enzyme, Contributing to a Higher Steady
State Level of c-Myc Ubiquitination and Subsequent
Degradation in A549 Cells
Degradation of c-Myc by Fbw7 can be reversed by the
ubiquitin-specific protease, USP28, which can form a ternary
complex with c-Myc and Fbw7a, in the nucleoplasm. To
investigate whether USP28 was involved in c-Myc degradation
initiated by hypoxia, the HA-cmv-USP28 expressing vector or
corresponding empty vector was transfected into A549 cells.
Following transfection, cells were treated with 1 mM NiSO4 or
hypoxia for 24 hrs, then lysed and c-Myc protein levels were
measured. As shown in Figure 5A, overexpression of USP28 in
A549 prevented the loss of c-Myc, suggesting that USP28 was
involved in c-Myc degradation.
To further explore these events, the effect of nickel ions on the
de-ubiquitination process of c-Myc was examined. Nickel ions or
hypoxia could impact the de-ubiquitination process by directly
inhibiting USP28 activity or indirectly decreasing USP28 activity
through either the dissociation of USP28 from the c-Myc-Fbw7a
complex or by a reduction of cellular USP28 levels. The possible
dissociation of USP28 from the c-Myc-Fbw7a complex by Ni ions
or hypoxia was investigated. A549 cells were transfected with c-
Myc expression plasmids, HA-tagged USP28, and Flga-tagged
Fbw7a and either not treated or exposed to 1 mM NiSO4 or
hypoxia in the presence of 4 mM proteasomal inhibitor MG-132.
After 24 hr of treatment, the cells were lysed and equal quantities
of protein were utilized for co-IP with anti-c-Myc (N-262)
antibody. Ni ions or hypoxia did not impair USP28 association
with the c-Myc-Fbw7a complex (Figure 5B). However, USP28
protein expression was decreased by Ni ions and hypoxia in the
A549 cells (Figure 5C). These outcomes indicated that a decreased
USP28 protein level caused less USP28 binding to the c-Myc-
Fbw7a complex, and sequentially increased the steady state
ubiquitination levels of c-Myc.
Hypoxia Decreased USP28 Protein Level through
Degradation and Transcriptional Repression in A549 Cells
Since both NiSO4 and hypoxia reduced USP28 protein level, we
asked whether HIF-1a and HIF-2a were involved in this decline.
As shown in Figure 6A, knockdown of both HIF-1a and HIF-2a
attenuated the decrease of USP28 protein level induced by Ni ions
or hypoxia. To determine whether a degradation process was
associated with decrease of USP28 protein level, A549 cells were
pretreated with a proteasomal inhibitor (MG-132), prior to their
exposure to Ni ions or hypoxia. The proteasomal inhibitor
prevented the loss of USP28 protein (Figure 6B). To further study
the mechanism of the hypoxia induced loss of cellular USP28
protein, real time quantitative PCR was conducted to assess the
effect of hypoxia on USP28 gene expression. Hypoxia exposure
Figure 4. Nickel ions and hypoxia increased phosphorylation levels of c-Myc at T58 in A549 cells but not through GSK3b. (A) A549
cells were pretreated with 4 mM proteasome inhibitor MG-132 for 2 hr and then exposed to NiSO4 (1 mM) or cultured in 1% O2 (Hy) for another 24 hr.
Immunoblotting of P-T58-Myc, total c-Myc, or a-tubulin was then performed as described in the Materials and Methods. The densitometric data,
presented between the blots, is expressed as density-ratio of P-T58-Myc band to corresponding total c-Myc band. (B–C) A549 cells were transfected
with non-coding control siRNA or siRNA targeting human GSK3b for 48 hr, and then were treated with NiSO4 (1.0 mM) or cultured under hypoxic
conditions (1% O2) in the absence (B) or presence of 4 mM MG-132 (C) for another 24 hr. After treatment, cells were lysed and 50 mg of whole cell
lysate was analyzed by Western blotting with the indicated antibodies. Similar data were obtained in at least two other independent experiments;
one representative blot is shown here.
doi:10.1371/journal.pone.0008531.g004
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that both degradation and gene repression were involved.
Nickel Ions and Hypoxia Increased the Dimethylation of
H3K9 in A549 Cells at the USP28 Promoter
Although little is known regarding the mechanisms by which the
expression of some genes are repressed by hypoxia signaling,
recent studies suggested that epigenetic mechanisms may be
involved. Nickel ions and hypoxia both increased global levels of
H3K9m2 [23,24,25], a critical mark for gene silencing. In support
of these findings, another study showed that Ni ions induced gpt
transgene silencing by increasing H3K9m2 levels at the promoter
of the gpt gene [24]. To investigate whether the Ni-induced
increase in H3K9m2 occurred at USP28 promoter region, a ChIP
assay using anti-H3K9m2 antibody was performed. Ni ions and
hypoxia increased the dimethylation of H3K9m2 at the promoter
of the USP28 gene in A549 cells (Figure 6D). To investigate
whether HIF-1a interacts with the USP28 promoter, since this
factor was required for the loss of USP28, another ChIP assay
using anti-HIF-1a antibody was conducted. However, there was
no observable interaction (between HIF-1a and the USP28
promoter region) induced by hypoxia signaling (data not shown).
HIF binding to HRE has only been reported as a mechanism for
gene activation by hypoxia, the downregulation of USP28 should
not result from HIF binding to HRE. However, it should be noted
that there are HRE boxes in the promoter of USP28. These results
indicated that the increase of H3K9m2 played an important role
in the repression of USP28 gene expression induced by hypoxia.
Discussion
Because of its critical role in cell growth, cellular c-Myc levels
must be tightly controlled, but on some occasions such as in
certain cancers, c-Myc has often been found to be overexpressed.
However, we observed a dose-dependent decline of c-Myc protein
following acute exposure to Ni compounds in a number of
tumorigenic cell lines (A549, MCF-7, MD453, and BT474 cells).
More detailed studies showed that the decreased c-Myc protein
level was due to an increased Ub-c-Myc and sequential
proteasomal degradation. It has been well known that Ni
compounds mimic hypoxia and activate/stabilize HIF-1a [7]. A
new finding reported here is that Ni compounds, DFO, DMOG,
and hypoxia all stabilized HIF-2a protein level in A549 cells.
Furthermore, DFO, DMOG and hypoxia decreased c-Myc in
A549 cells suggesting that hypoxia functions in the decline of c-
Myc.
The role of HIF-1a and HIF-2a in c-Myc degradation induced
by Ni ions or hypoxia was verified in A549 cells. It was observed
that knocking down HIF-1a or HIF-2a alone failed to block the
decrease in c-Myc protein levels initiated by Ni ions or to hypoxia;
c-Myc protein degradation ceased only when both HIF-1a and
HIF-2a were removed. Mounting experimental evidence indicates
that there are distinct functions for HIF-1a and HIF-2a during
tumor growth [26,27], and that there is little redundancy between
the two a subunits [28]. However, our findings suggest that HIF-
1a and HIF-2a do seem to share in the degradation of c-Myc. This
‘‘shared’’ function status might be specific to the hypoxic state.
Figure 5. The decrease of USP28 protein levels induced by Ni ions or hypoxia contributed to c-Myc degradation in A549 cells. (A)
A549 cells were transfected with 1.0 mg or 1.5 mg HA-tagged USP28 plasmid or empty vector. 24 hr after transfection, cells were treated with NiSO4
(1.0 mM) or cultured in 1% O2 (Hy) for another 24 hr. Cells were then lysed and protein levels were analyzed by immunoblotting. The densitometric
data (of c-Myc), normalized to a-tubulin level, is expressed as fold-change from control; these values are presented between the blots. (B) Ni ions or
hypoxia did not induce dissociation of USP28 or Fbw7 from c-Myc. A549 cells were co-transfected with pRC-cmv-Myc, HA-USP28, and Flag-Fbw7a-
expressing plasmids. 24 hr after transfection, cells were treated with NiSO4 (1.0 mM) or cultured in 1% O2 in the presence of MG-132 (4 mM) for
another 24 hr. After treatment, cells were lysed and immunoprecipitated with anti-c-Myc (N-262) antibody. Precipitates were analyzed by
immunoblotting with indicated antibodies. (C) A549 cells were treated with NiSO4 (1.0 mM) or cultured in 1% O2 for 24 hr. Cells were then lysed and
protein levels were analyzed by immunoblotting.
doi:10.1371/journal.pone.0008531.g005
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1a and HIF-2a failed to give rise to an increase in c-Myc protein
levels above background values at normal oxygen tension. This
suggests that the HIFs are not involved in the regulation of
constitutive c-Myc protein stability in tumorigenic cells under
normoxic conditions.
In cancerous cells, c-Myc is frequently over-expressed and
stabilized by an unknown mechanism for promoting cell
proliferation and mitochondrial respiration through increasing
mitochondrial biogenesis [29]. In contrast, HIF-1 and HIF-2 have
already been shown to inhibit mitochondrial biogenesis [5].
Previous studies have suggested that the destruction of c-Myc may
be linked to its activity as a transcription factor [19,30].
Accordingly, the opposing effects of HIFs and c-Myc on
mitochondrial biogenesis may require the HIFs to repress c-Myc
activity to ensure efficient attenuation of mitochondrial biogenesis,
one manifestation of which may be the proteasomal degradation of
c-Myc (mediated by HIFs). Thus, a greater understanding as to
how HIFs induce c-Myc degradation may provide useful
information for developing novel strategies to target tumor
hypoxia and regulation of mitochondrial activity in cancer cells.
Two pathways for ubiquitin-dependent proteolysis are critically
important for regulating c-Myc turnover: Fbw7 and Skp2. The
results here demonstrated that hypoxia signaling was dependent
upon Fbw7, but not Skp2, ubiquitin ligase. Mutating the T58 of c-
Myc with alanine prevented the loss of c-Myc, suggesting that
hypoxia signaling degraded c-Myc in a T58-phosphorylation-
dependent manner. Further investigation of the underlying
mechanism revealed that P-T58-Myc levels were dramatically
increased after exposure to Ni ions or hypoxia (in the absence or
presence of MG-132), which in turn would result in increase Ub-c-
Myc levels. However, GSK3b, which has been reported to be the
only enzyme to catalyze the phosphorylation of c-Myc at T58, did
not appear to be involved in the degradation of c-Myc induced by
hypoxia. In addition, knocking down GSK3b did not decrease P-
T58-Myc levels. This paradoxical result indicated that GSK3b was
not the only enzyme to phosphorylate c-Myc at T58 in A549 cells.
Previous studies have shown that degradation of c-Myc by
Fbw7a was antagonized by an ubiquitin-specific protease, USP28
[31]. Because c-Myc is continuously ubiquitinated and de-
ubiquitinated in the nucleoplasm, Ni ions (and hypoxia) might
also be able to regulate c-Myc stability through effects upon USP28
activity and/or association with Fbw7. An earlier study showed
that the degradation of c-Myc by UV irradiation was mediated by
the dissociation of USP28 from Fbw7a and c-Myc [32],
demonstrating that USP28 was involved in the degradation of c-
Myc. Although further studies did not show that hypoxia signaling
impaired the association of USP28 with Fbw7a and c-Myc, cellular
USP28 protein levels were decreased by Ni ions and hypoxia in
A549 cells. This decline in total protein resulted in decreased
endogenous USP28 binding to Fbw7a and c-Myc, which increased
the levels of Ub-c-Myc.
Figure 6. USP28 protein level was decreased by hypoxia signaling via both protein degradation and transcriptional repression in
A549 cells. (A) A549 cells were transfected with non-coding control siRNA or siRNA targeting human HIF-1a and HIF-2a (HIF-1a RNAi and HIF-2a RNAi
mixture) for 48 hr, and then were treated with 1.0 mM NiSO4 or cultured in 1% O2 (Hy) for another 24 hr. (B) A549 cells were pretreated with 4 mM
proteasome inhibitor MG-132 for 2 hr and then exposed to 1 mM of NiSO4 or cultured under 1% O2 for another 24 hr. After treatment, cells were
lysed and 50 mg of whole cell lysate was analyzed by Western blotting. (C) Hypoxia decreased USP28 mRNA levels in A549 cells. A549 cells were
cultured in 1% O2 for 24 hr. After treatment, RNA was isolated for quantitative Real Time-PCR. Two tailed Student’s T-test was used to analyze the fold
change. Data are expressed as mean6SEM, obtained from three independent experiments; n=3 in each experiment; *statistically significant change
(p,0.05) when compared to control samples. (D) A549 cells were treated with 1 mM NiSO4 or cultured under hypoxic conditions (1% O2) for 24 hr.
After treatment, the chromatin from ,2610
7 cells was isolated and subjected to a ChIP assay as described in the Materials and Methods. Input DNA
fractions were amplified by PCR to assess the chromatin loading.
doi:10.1371/journal.pone.0008531.g006
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activation of HIF-1a and HIF-2a. Since USP28 was shown to be
regulated by Ni ions and hypoxia, HIFs may function in this
process. Knocking down both HIF-1a and HIF-2a attenuated the
decrease in USP28 levels attributable to hypoxia signaling. Further
studies showed that USP28 proteins were also degraded through a
proteasomal pathway and USP28 mRNA level was significantly
decreased by hypoxia. Therefore, both protein degradation and
transcriptional repression contributed to a decrease in USP28
protein.
Previous studies have shown that both Ni ions and hypoxia
induced an increase in global levels of dimethylated histone H3
lysine 9 (H3K9m2) in mammalian cells [24,25]. H3K9 dimethyla-
tion has been shown to correlate with gene repression by either
recruiting heterochromatin protein 1 (HP1) to chromatin, or
leading to histone deacetylation in both H3 and H4 [33,34]. Here,
it has been demonstrated that Ni ions and hypoxia increased
H3K9m2 levels at the USP28 promoter and repressed USP28 gene
expression.
The enzyme-catalyzed methylation of histone lysine is
controlled by both a methylation and a demethylation process.
Hypoxia and Ni ions have been reported to increase global
H3K9m2 mostly by the oxidative histone demethylation
processes [24,25]. A Newly-identified H3K9m2-specific de-
methylases, i.e., JmjC-containing JHDM2 proteins, are iron-
and a-ketoglutarate-dependent oxygenases [35]. Although stud-
ies showed that JHDM2A (also known as JMJD1A) was up-
regulated in response to low oxygen levels in vitro and in vivo [36],
its enzymatic activity should be inhibited when O2 w a sa sl o wa s
1%. In addition, it was found that Ni ions inhibited JHDM2A
enzyme activityin vitro by interfering with the binding of iron with
t h ee n z y m e[ 3 7 ] .
In summary, this study demonstrates that Ni compounds and
hypoxia induced proteasomal degradation of c-Myc through HIF-
1a and HIF-2a involving both Fbw7 and T58-phosphorylation.
There were two scenarios that resulted in an increase in
ubiquitinated c-Myc levels in A549 cells: the first involved an
increased phosphorylation of c-Myc at T58; and the second
involved a decrease in USP28 protein levels partially mediated by
HIF-1 and HIF-2. The reduction of USP28 protein by hypoxia
signaling is due to both transcriptional repression and protein
degradation. Both Ni ions and hypoxia increased the levels of
dimethylated H3 lysine 9 at the USP28 promoter and repressed its
expression.
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